XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Total Stockholders’ Equity
Total Stockholders’ Equity
Cumulative Effect, Period of Adoption, Adjustment
Total Stockholders’ Equity
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury Stock
Treasury Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Noncontrolling Interest
Noncontrolling Interest
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2022             25,349,225                    
Beginning balance at Dec. 31, 2022 $ 568,887     $ 568,798     $ 127,004   $ 646,100     $ (188,923)   $ (15,383)   $ 89  
Increase (Decrease) in Stockholders' Equity                                  
Net income 64,141     64,141         64,141                
Other comprehensive income (loss), net of tax (39,188)     (39,188)               (39,188)          
Cash dividends declared and paid (35,324)     (35,324)         (35,324)                
Treasury shares purchased under deferred directors' plan (in shares)             (8,493)                    
Treasury shares purchased under deferred directors' plan 0     0     $ 491             (491)      
Treasury shares sold and distributed under deferred directors' plan (in shares)             12,855                    
Treasury shares sold and distributed under deferred directors' plan 0     0     $ (405)             405      
Stock activity under equity compensation plans (in shares)             78,137                    
Stock activity under equity compensation plans (3,124)     (3,124)     $ (3,124)                    
Stock based compensation expense 1,792     1,792     $ 1,792                    
Ending balance (in shares) at Sep. 30, 2023             25,431,724                    
Ending balance at Sep. 30, 2023 557,184     557,095     $ 125,758   674,917     (228,111)   (15,469)   89  
Beginning balance (in shares) at Dec. 31, 2022             25,349,225                    
Beginning balance at Dec. 31, 2022 $ 568,887     568,798     $ 127,004   646,100     (188,923)   (15,383)   89  
Increase (Decrease) in Stockholders' Equity                                  
Accounting standards update Accounting Standards Update 2023-02 [Member]                                
Ending balance (in shares) at Dec. 31, 2023 25,430,566           25,430,566 25,430,566                  
Ending balance at Dec. 31, 2023 $ 649,793 $ (532) $ 649,261 649,704 $ (532) $ 649,172 $ 127,692 $ 127,692 692,760 $ (532) $ 692,228 (155,195) $ (155,195) (15,553) $ (15,553) 89 $ 89
Beginning balance (in shares) at Jun. 30, 2023             25,429,216                    
Beginning balance at Jun. 30, 2023 591,995     591,906     $ 123,367   661,447     (177,645)   (15,263)   89  
Increase (Decrease) in Stockholders' Equity                                  
Net income 25,252     25,252         25,252                
Other comprehensive income (loss), net of tax (50,466)     (50,466)               (50,466)          
Cash dividends declared and paid (11,782)     (11,782)         (11,782)                
Treasury shares purchased under deferred directors' plan (in shares)             (3,992)                    
Treasury shares purchased under deferred directors' plan 0     0     $ 206             (206)      
Stock activity under equity compensation plans (in shares)             6,500                    
Stock activity under equity compensation plans 0     0                          
Stock based compensation expense 2,185     2,185     $ 2,185                    
Ending balance (in shares) at Sep. 30, 2023             25,431,724                    
Ending balance at Sep. 30, 2023 $ 557,184     557,095     $ 125,758   674,917     (228,111)   (15,469)   89  
Beginning balance (in shares) at Dec. 31, 2023 25,430,566           25,430,566 25,430,566                  
Beginning balance at Dec. 31, 2023 $ 649,793 $ (532) $ 649,261 649,704 $ (532) $ 649,172 $ 127,692 $ 127,692 692,760 $ (532) $ 692,228 (155,195) $ (155,195) (15,553) $ (15,553) 89 $ 89
Increase (Decrease) in Stockholders' Equity                                  
Net income 69,288     69,288         69,288                
Other comprehensive income (loss), net of tax 17,059     17,059               17,059          
Cash dividends declared and paid (36,966)     (36,966)         (36,966)                
Treasury shares purchased under deferred directors' plan (in shares)             (8,088)                    
Treasury shares purchased under deferred directors' plan 0     0     $ 506             (506)      
Treasury shares sold and distributed under deferred directors' plan (in shares)             13,275                    
Treasury shares sold and distributed under deferred directors' plan 0     0     $ (391)             391      
Stock activity under equity compensation plans (in shares)             70,331                    
Stock activity under equity compensation plans (2,596)     (2,596)     $ (2,596)                    
Stock based compensation expense $ 3,135     3,135     $ 3,135                    
Ending balance (in shares) at Sep. 30, 2024 25,506,084           25,506,084                    
Ending balance at Sep. 30, 2024 $ 699,181     699,092     $ 128,346   724,550     (138,136)   (15,668)   89  
Beginning balance (in shares) at Jun. 30, 2024             25,503,744                    
Beginning balance at Jun. 30, 2024 654,590     654,501     $ 126,871   713,541     (170,458)   (15,453)   89  
Increase (Decrease) in Stockholders' Equity                                  
Net income 23,338     23,338         23,338                
Other comprehensive income (loss), net of tax 32,322     32,322               32,322          
Cash dividends declared and paid (12,329)     (12,329)         (12,329)                
Treasury shares purchased under deferred directors' plan (in shares)             (3,510)                    
Treasury shares purchased under deferred directors' plan 0     0     $ 215             (215)      
Stock activity under equity compensation plans (in shares)             5,850                    
Stock activity under equity compensation plans 0     0                          
Stock based compensation expense $ 1,260     1,260     $ 1,260                    
Ending balance (in shares) at Sep. 30, 2024 25,506,084           25,506,084                    
Ending balance at Sep. 30, 2024 $ 699,181     $ 699,092     $ 128,346   $ 724,550     $ (138,136)   $ (15,668)   $ 89